In this issue:
Preoperative chemotherapy: survival benefit in NSCLC
EGFR TKIs beneficial in EGFR FISH-amplified NSCLC
NSCLC trial outcomes: unwelcome interpretations
Bevacizumab + CTX in platinum-resistant OC
Patient-reported outcomes on bevacizumab + CTX in OC
CTX ± cetuximab in resectable CLMs
Converting unresectable CLMs
Consider oophorectomy for BRCA1 carriers?
Prognostic factors and survival in primary GIST
Organic foods do not lower overall cancer risk
Please login below to download this issue (PDF)